Remove ads
Found in articles
PD-1/PD-L1抑制剂是一组用于治疗癌症的免疫检查点抑制剂（英语：Checkpoint inhibitor）。PD-1（英语：PD-1）和PD-L1都是存在于细胞表面的蛋白质。此类的免疫检查点抑制剂正在成为几种癌症的一线治疗药物。 PD-1/PD-L1抑制剂能抑制程序性死亡配体-1（PD-L1）
National Library of Medicine. De-novo and acquired resistance to immune checkpoint targeting. The Lancet. Oncology. December 2017, 18 (12): e731–e741
伏妥珠单抗
Kantarjian H, Ravandi F, Daver N. Immune therapies in acute myeloid leukemia: a focus on monoclonal antibodies and immune checkpoint inhibitors. Curr. Opin. Hematol
1038/nm0303-269. （原始内容存档于2020-10-28）. Sharma P, Allison JP. The future of immune checkpoint therapy. Science. April 2015, 348 (6230): 56–61. Bibcode:2015Sci.
future of immune checkpoint therapy. Science. April 2015, 348 (6230): 56–61. PMID 25838373. doi:10.1126/science.aaa8172. A Pollack. Drug helps immune system